Dr. Michael Regn is an accomplished professional currently serving as the Global Strategic Initiatives Lead in R&D at Roche, where they have been since 2024. Prior to this role, Dr. Regn held various positions at Roche, including Global Program Leader from 2022 to 2024 and Manager R&D from 2016 to 2019. Dr. Regn began their career as a Consultant at The Boston Consulting Group in 2011 and further developed their expertise as a Wissenschaftlicher Mitarbeiter at Friedrich-Alexander-Universität Erlangen-Nürnberg. They earned a PhD in Pharmacology and Toxicology from Technische Universität München in 2016, following a Diplom in Molecular Medicine from the same institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices